4//SEC Filing
VAN OORT DOUGLAS M 4
Accession 0001077183-21-000086
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:19 PM ET
Size
12.7 KB
Accession
0001077183-21-000086
Insider Transaction Report
Form 4
VAN OORT DOUGLAS M
DirectorChairman and CEO
Transactions
- Tax Payment
Common Stock
2021-03-02−2,158→ 2,418,293 total - Award
Common Stock
2021-03-02+56,423→ 2,474,716 total - Tax Payment
Common Stock
2021-03-01−2,339→ 2,420,451 total
Holdings
- 231,567
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (231,567 underlying) - 225,084
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (225,084 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (500,000 underlying) - 15,000(indirect: By Children)
Common Stock
Footnotes (5)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
- [F3]On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001518733
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:19 PM ET
- Size
- 12.7 KB